Valuation check: SWTX's PEG ratio is 281.07, above the Healthcare sector average of 2.56.
Get informed when a big investor buys or sells
+ Follow281.07
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
As of the most recent data, SWTX shows a PEG ratio of 281.07. That is above the Healthcare sector average of 2.56. Scroll down for historical charts and peer comparison views.
The Healthcare sector average PEG ratio is about 2.56. SpringWorks Therapeutics is at 281.07, which is higher that average. That is roughly 10880.7% above the sector mean. Use the comparison chart on this page to see how SWTX stacks up against individual peers as well.
Investors watch SWTX's PEG ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. SpringWorks Therapeutics's latest reading is 281.07. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this peg ratio page, Stockcircle has SpringWorks Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect PEG ratio (currently 281.07) with ownership activity and broader fundamentals.
The Healthcare average PEG ratio is about 2.56, while SWTX is at 281.07. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.